Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity
- PMID: 2338244
- DOI: 10.1101/gad.4.2.233
Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity
Abstract
Transcriptional enhancers of replication-competent mouse C-type retroviruses are potent determinants of the distinct disease-inducing phenotypes of different viral isolates and can also strongly influence the incidence and latent period of disease induction. To study the contribution of individual protein-binding sites to viral pathogenicity, we introduced mutations into each of the known nuclear factor-binding sites in the enhancer region of the Moloney murine leukemia virus and injected viruses with these mutations into newborn NFS mice. All viruses induced disease. Viruses with mutations in both copies of the leukemia virus factor a (LVa) site, leukemia virus factor c (LVc) site, or in just the promoter proximal copy of the glucocorticoid response element (GRE) had a latent period of disease onset and disease specificity indistinguishable from that of the wild-type Moloney virus. Viruses with mutations in two or three of the GREs, in both copies of the leukemia virus factor b (LVb) site, in two of the four nuclear factor 1 (NF1) consensus motifs, or in both copies of the conserved viral core element showed a significant delay in latent period of disease induction. Strikingly, viruses with mutations in the core element induced primarily erythroleukemias, and mutations in the LVb site also resulted in a significant incidence of erythroleukemias. These and other genetic and biochemical studies suggest models for how subtle alterations in the highly conserved structure of mouse C-type retrovirus enhancers can produce a dramatic effect on disease specificity.
Similar articles
-
Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.J Virol. 1989 Jan;63(1):328-37. doi: 10.1128/JVI.63.1.328-337.1989. J Virol. 1989. PMID: 2783259 Free PMC article.
-
Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.J Virol. 1993 Apr;67(4):1967-75. doi: 10.1128/JVI.67.4.1967-1975.1993. J Virol. 1993. PMID: 8445718 Free PMC article.
-
Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.J Virol. 1990 Feb;64(2):543-50. doi: 10.1128/JVI.64.2.543-550.1990. J Virol. 1990. PMID: 2104942 Free PMC article.
-
Genetic basis of disease specificity of nondefective Friend murine leukemia virus.Ann N Y Acad Sci. 1989;567:14-25. doi: 10.1111/j.1749-6632.1989.tb16455.x. Ann N Y Acad Sci. 1989. PMID: 2679314 Review. No abstract available.
-
Moloney murine leukemia virus temperature-sensitive mutants: a model for retrovirus-induced neurologic disorders.Curr Top Microbiol Immunol. 1990;160:29-60. doi: 10.1007/978-3-642-75267-4_3. Curr Top Microbiol Immunol. 1990. PMID: 2162285 Review. No abstract available.
Cited by
-
Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2.Mol Cell Biol. 2000 Jan;20(1):81-90. doi: 10.1128/MCB.20.1.81-90.2000. Mol Cell Biol. 2000. PMID: 10594011 Free PMC article.
-
Selection for c-myc integration sites in polyclonal T-cell lymphomas.J Virol. 2002 Mar;76(5):2087-99. doi: 10.1128/jvi.76.5.2087-2099.2002. J Virol. 2002. PMID: 11836386 Free PMC article.
-
Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.J Virol. 1994 Aug;68(8):5174-83. doi: 10.1128/JVI.68.8.5174-5183.1994. J Virol. 1994. PMID: 8035516 Free PMC article.
-
The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.J Virol. 1997 Dec;71(12):9786-91. doi: 10.1128/JVI.71.12.9786-9791.1997. J Virol. 1997. PMID: 9371646 Free PMC article.
-
Molecular cloning of osteoma-inducing replication-competent murine leukemia viruses from the RFB osteoma virus stock.J Virol. 1992 Oct;66(10):6186-90. doi: 10.1128/JVI.66.10.6186-6190.1992. J Virol. 1992. PMID: 1326664 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous